Professor | Chengyu Zou | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Chengyu Zou

Contact Information

czou@mail.sioc.ac.cn

Language ability

Chinese, English, German

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Life Sciences
Academic Background & Achievements	2011-09--2015-11 PhD: Ludwig Maximilian University of Munich 2008-09--2011-06 Master's: Chongqing University 2004-09--2008-06 Bachelor's: Southwest University
Work Experience	2016-03~2021-01 - Harvard Medical School - Postdoctoral Researcher 2011-09~2015-11 - Ludwig Maximilian University of Munich - PhD 2008-09~2011-06 - Chongqing University - Master's 2004-09~2008-06 - Southwest University - Bachelor's

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Life Sciences

Academic Background & Achievements

Work Experience

Areas of Focus	Neurodegenerative Diseases Cell Death and Inflammation
Publications	Elevated peripheral levels of receptor-interacting protein kinase 1 (RIPK1) and IL-8 as biomarkers of human amyotrophic lateral sclerosis, 8th Author, 2023 Myeloid-derived MIF drives RIPK1-mediated cerebromicrovascular endothelial cell death to exacerbate ischemic brain injury, 2nd Author, 2023 Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO), 8th Author, 2022 Microglial Dysfunction in Neurodegenerative Diseases via RIPK1 and ROS, 11th Author, 2022 Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response, 3rd Author, 2022 Genetic Regulation of RIPK1 and Necroptosis, 2nd Author, 2021 A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis, 11th Author, 2021 Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer’s Disease, 1st Author, 2020 NEK1-mediated retromer trafficking promotes blood-brain barrier integrity by regulating glucose metabolism and RIPK1 activation, 1st Author, 2020

Areas of Focus

Neurodegenerative Diseases
Cell Death and Inflammation

Publications

Elevated peripheral levels of receptor-interacting protein kinase 1 (RIPK1) and IL-8 as biomarkers of human amyotrophic lateral sclerosis, 8th Author, 2023
Myeloid-derived MIF drives RIPK1-mediated cerebromicrovascular endothelial cell death to exacerbate ischemic brain injury, 2nd Author, 2023
Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO), 8th Author, 2022
Microglial Dysfunction in Neurodegenerative Diseases via RIPK1 and ROS, 11th Author, 2022
Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response, 3rd Author, 2022
Genetic Regulation of RIPK1 and Necroptosis, 2nd Author, 2021
A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis, 11th Author, 2021
Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer’s Disease, 1st Author, 2020
NEK1-mediated retromer trafficking promotes blood-brain barrier integrity by regulating glucose metabolism and RIPK1 activation, 1st Author, 2020

Neurodegenerative Diseases Cell Death Inflammation Ripk1 Als Alzheimer'S Disease Microglia Endothelial Cell Death Ischemic Brain Injury Necroptosis

Yujun Hou - Tongji University

Gang Pei - Tongji University

Ru Zhang - Tongji University

View All

Personal Information